
To investigate potential clinical and multimodal imaging factors in central serous chorioretinopathy (CSC) recurrence. In total, 538 eyes (538 patients) diagnosed with CSC were enrolled. Among them, 253 eyes (47.0%) developed ≥1 recurrence. Patients with CSC who received corticosteroids and had bilateral disease, chronic manifestation, non‐intense fluorescein leakage on fluorescein angiography or a relatively thinner CRT should be closely monitored to identify whether they are at high risk of recurrence.
Like
Save
Share